Literature DB >> 22547473

Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.

Heidi D Nelson1, Bernadette Zakher, Amy Cantor, Rongwei Fu, Jessica Griffin, Ellen S O'Meara, Diana S M Buist, Karla Kerlikowske, Nicolien T van Ravesteyn, Amy Trentham-Dietz, Jeanne S Mandelblatt, Diana L Miglioretti.   

Abstract

BACKGROUND: Identifying risk factors for breast cancer specific to women in their 40s could inform screening decisions.
PURPOSE: To determine what factors increase risk for breast cancer in women aged 40 to 49 years and the magnitude of risk for each factor. DATA SOURCES: MEDLINE (January 1996 to the second week of November 2011), Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (fourth quarter of 2011), Scopus, reference lists of published studies, and the Breast Cancer Surveillance Consortium. STUDY SELECTION: English-language studies and systematic reviews of risk factors for breast cancer in women aged 40 to 49 years. Additional inclusion criteria were applied for each risk factor. DATA EXTRACTION: Data on participants, study design, analysis, follow-up, and outcomes were abstracted. Study quality was rated by using established criteria, and only studies rated as good or fair were included. Results were summarized by using meta-analysis when sufficient studies were available or from the best evidence based on study quality, size, and applicability when meta-analysis was not possible. Data from the Breast Cancer Surveillance Consortium were analyzed with proportional hazards models by using partly conditional Cox regression. Reference groups for comparisons were set at U.S. population means. DATA SYNTHESIS: Sixty-six studies provided data for estimates. Extremely dense breasts on mammography or first-degree relatives with breast cancer were associated with at least a 2-fold increase in risk for breast cancer. Prior breast biopsy, second-degree relatives with breast cancer, or heterogeneously dense breasts were associated with a 1.5- to 2.0-fold increased risk; current use of oral contraceptives, nulliparity, and age 30 years or older at first birth were associated with a 1.0- to 1.5-fold increased risk. LIMITATIONS: Studies varied by measures, reference groups, and adjustment for confounders, which could bias combined estimates. Effects of multiple risk factors were not considered.
CONCLUSION: Extremely dense breasts and first-degree relatives with breast cancer were each associated with at least a 2-fold increase in risk for breast cancer in women aged 40 to 49 years. Identification of these risk factors may be useful for personalized mammography screening. PRIMARY FUNDING SOURCE: National Cancer Institute.

Entities:  

Mesh:

Year:  2012        PMID: 22547473      PMCID: PMC3561467          DOI: 10.7326/0003-4819-156-9-201205010-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  110 in total

1.  Body size and breast cancer risk among women under age 45 years.

Authors:  C A Swanson; R J Coates; J B Schoenberg; K E Malone; M D Gammon; J L Stanford; I J Shorr; N A Potischman; L A Brinton
Journal:  Am J Epidemiol       Date:  1996-04-01       Impact factor: 4.897

2.  Cigarette smoking and the risk of breast cancer.

Authors:  C Braga; E Negri; C La Vecchia; R Filiberti; S Franceschi
Journal:  Eur J Cancer Prev       Date:  1996-06       Impact factor: 2.497

3.  The role of reproductive and menstrual factors in cancer of the breast before and after menopause.

Authors:  R Talamini; S Franceschi; C La Vecchia; E Negri; L Borsa; M Montella; F Falcini; E Conti; C Rossi
Journal:  Eur J Cancer       Date:  1996-02       Impact factor: 9.162

4.  Recent oral contraceptive use and risk of breast cancer (United States)

Authors:  P A Newcomb; M P Longnecker; B E Storer; R Mittendorf; J Baron; R W Clapp; A Trentham-Dietz; W C Willett
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

5.  Progestogen-only oral contraceptives and risk of breast cancer in New Zealand.

Authors:  D C Skegg; C Paul; G F Spears; S M Williams
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

6.  Body size indices and breast cancer risk before and after menopause.

Authors:  S Franceschi; A Favero; C La Vecchia; A E Barón; E Negri; L Dal Maso; A Giacosa; M Montella; E Conti; D Amadori
Journal:  Int J Cancer       Date:  1996-07-17       Impact factor: 7.396

7.  Lactation and the risk of breast cancer in an Italian population.

Authors:  E Negri; C Braga; C La Vecchia; F Levi; R Talamini; S Franceschi
Journal:  Int J Cancer       Date:  1996-07-17       Impact factor: 7.396

8.  A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States).

Authors:  S E Hankinson; G A Colditz; J E Manson; W C Willett; D J Hunter; M J Stampfer; F E Speizer
Journal:  Cancer Causes Control       Date:  1997-01       Impact factor: 2.506

9.  Leisure-time physical activity in relation to breast cancer among young women (Washington, United States).

Authors:  C L Chen; E White; K E Malone; J R Daling
Journal:  Cancer Causes Control       Date:  1997-01       Impact factor: 2.506

10.  Cigarette smoking and breast cancer.

Authors:  J A Baron; P A Newcomb; M P Longnecker; R Mittendorf; B E Storer; R W Clapp; G Bogdan; J Yuen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-05       Impact factor: 4.254

View more
  118 in total

1.  Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects.

Authors:  Bin Kong; Zhi-Dong Lv; Li Chen; Ruo-Wu Shen; Li-Ying Jin; Zhao-Chuan Yang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.

Authors:  Jeanne S Mandelblatt; Natasha K Stout; Clyde B Schechter; Jeroen J van den Broek; Diana L Miglioretti; Martin Krapcho; Amy Trentham-Dietz; Diego Munoz; Sandra J Lee; Donald A Berry; Nicolien T van Ravesteyn; Oguzhan Alagoz; Karla Kerlikowske; Anna N A Tosteson; Aimee M Near; Amanda Hoeffken; Yaojen Chang; Eveline A Heijnsdijk; Gary Chisholm; Xuelin Huang; Hui Huang; Mehmet Ali Ergun; Ronald Gangnon; Brian L Sprague; Sylvia Plevritis; Eric Feuer; Harry J de Koning; Kathleen A Cronin
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

3.  Towards research-tested smartphone applications for preventing breast cancer.

Authors:  Steven S Coughlin; Herpreet Thind; Benyuan Liu; Lt Col Candy Wilson
Journal:  Mhealth       Date:  2016-06-21

4.  Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

Authors:  A Jafarzadeh; H Fooladseresht; K Minaee; M R Bazrafshani; A Khosravimashizi; M Nemati; M Mohammadizadeh; M M Mohammadi; A Ghaderi
Journal:  Tumour Biol       Date:  2014-10-22

5.  Does and should breast cancer genetic counselling include lifestyle advice?

Authors:  Akke Albada; Madelèn Vernooij; Liesbeth van Osch; Anouk Pijpe; Sandra van Dulmen; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

6.  Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.

Authors:  Cristina O'Donoghue; Martin Eklund; Elissa M Ozanne; Laura J Esserman
Journal:  Ann Intern Med       Date:  2014-02-04       Impact factor: 25.391

7.  Prediction of near-term breast cancer risk based on bilateral mammographic feature asymmetry.

Authors:  Maxine Tan; Bin Zheng; Pandiyarajan Ramalingam; David Gur
Journal:  Acad Radiol       Date:  2013-12       Impact factor: 3.173

8.  Examining the etiology of early-onset breast cancer in the Canadian Partnership for Tomorrow's Health (CanPath).

Authors:  Joy Pader; Robert B Basmadjian; Dylan E O'Sullivan; Nicole E Mealey; Yibing Ruan; Christine Friedenreich; Rachel Murphy; Edwin Wang; May Lynn Quan; Darren R Brenner
Journal:  Cancer Causes Control       Date:  2021-06-25       Impact factor: 2.506

9.  Correlations of common polymorphism of EVI-1 gene targeted by miRNA-206/133b with the pathogenesis of breast cancer.

Authors:  Tian-Yi Wang; Yin-Peng Huang; Ping Ma
Journal:  Tumour Biol       Date:  2014-06-17

10.  The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update.

Authors:  Oguzhan Alagoz; Mehmet Ali Ergun; Mucahit Cevik; Brian L Sprague; Dennis G Fryback; Ronald E Gangnon; John M Hampton; Natasha K Stout; Amy Trentham-Dietz
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.